Avadel Pharma (AVDL) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts AVDL Hot Sheet
Join SI Premium – FREE
Avadel Pharma (NASDAQ: AVDL) reported Q3 EPS of ($0.33), $0.03 worse than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Canaccord Reiterates Buy Rating on HubSpot Inc (HUBS)
- Needham Reiterates Hold Rating on Envista Holdings Corp. (NVST)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
